COVID-19 vaccine EUA for 5-11 year olds is expected, which will be used to construct rigid mandates. The FDA and CDC need to consider the specific risk-benefit of the COVID-recovered child.
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.